Your browser doesn't support javascript.
loading
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Othman, Tamer; Quan, Michelle A; Zhang, Shiliang; Gaut, Daria; Young, Patricia A; Mahmood, Omar; Abdulhaq, Haifaa; Shieh, Kevin; Reid, Jack; Brem, Elizabeth A; Hariharan, Nisha; Heyman, Benjamin; Tuscano, Joseph.
Affiliation
  • Othman T; Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA.
  • Quan MA; Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA.
  • Zhang S; Division of Hematology Oncology, David Geffen School of Medicine and University of California, Los Angeles, CA.
  • Gaut D; Division of Hematology Oncology, David Geffen School of Medicine and University of California, Los Angeles, CA.
  • Young PA; Division of Hematology Oncology, David Geffen School of Medicine and University of California, Los Angeles, CA.
  • Mahmood O; Department of Medicine, University of California San Francisco, Fresno campus, Fresno, CA.
  • Abdulhaq H; Department of Medicine, University of California San Francisco, Fresno campus, Fresno, CA.
  • Shieh K; Division of Blood & Marrow Transplant, Department of Medicine, University of California, San Diego Health, La Jolla, CA.
  • Reid J; Division of Blood & Marrow Transplant, Department of Medicine, University of California, San Diego Health, La Jolla, CA.
  • Brem EA; Division of Blood & Marrow Transplant, Department of Medicine, University of California, San Diego Health, La Jolla, CA.
  • Hariharan N; Moores Cancer Center, University of California, San Diego, La Jolla, CA.
  • Heyman B; Moores Cancer Center, University of California, San Diego, La Jolla, CA.
  • Tuscano J; Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA. Electronic address: jtuscano@ucdavis.edu.
Clin Lymphoma Myeloma Leuk ; 23(10): 749-756, 2023 10.
Article in En | MEDLINE | ID: mdl-37336714
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Lymphoma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Lymphoma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Canada Country of publication: United States